Amiodarone hepatotoxicity. 1986

L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter

UI MeSH Term Description Entries
D008064 Lipidoses Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved. Lipidosis,Lipoidosis
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
July 2008, Current vascular pharmacology,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
January 2012, Hepatology (Baltimore, Md.),
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
January 1986, The New England journal of medicine,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
January 1997, Digestive diseases (Basel, Switzerland),
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
January 1986, Acta medica Scandinavica,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
January 2007, Indian heart journal,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
November 1992, Annals of the Academy of Medicine, Singapore,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
November 2023, BMJ case reports,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
September 1995, Minerva medica,
L D Elving, and W H Hoefnagels, and U J Van Haelst, and G Griffioen, and A R Janssens, and D J Ruiter
April 2012, European journal of clinical pharmacology,
Copied contents to your clipboard!